Your browser doesn't support javascript.
loading
Pediatric Bacterial Meningitis Surveillance in Nigeria From 2010 to 2016, Prior to and During the Phased Introduction of the 10-Valent Pneumococcal Conjugate Vaccine.
Tagbo, Beckie N; Bancroft, Rowan E; Fajolu, Iretiola; Abdulkadir, Mohammed B; Bashir, Muhammad F; Okunola, Olusola P; Isiaka, Ayodeji H; Lawal, Namadi M; Edelu, Benedict O; Onyejiaka, Ngozi; Ihuoma, Chinonyerem J; Ndu, Florence; Ozumba, Uchenna C; Udeinya, Frances; Ogunsola, Folasade; Saka, Aishat O; Fadeyi, Abayomi; Aderibigbe, Sunday A; Abdulraheem, Jimoh; Yusuf, Adamu G; Sylvanus Ndow, Peter; Ogbogu, Philomena; Kanu, Chinomnso; Emina, Velly; Makinwa, Olajumoke J; Gehre, Florian; Yusuf, Kabir; Braka, Fiona; Mwenda, Jason M; Ticha, Johnson M; Nwodo, Dorothy; Worwui, Archibald; Biey, Joseph N; Kwambana-Adams, Brenda A; Antonio, Martin.
Afiliación
  • Tagbo BN; Institute of Child Health, University of Nigeria Teaching Hospital, Ituku-Ozalla, and.
  • Bancroft RE; Department of Paediatrics University of Nigeria Teaching Hospital Ituku-Ozalla, Enugu State.
  • Fajolu I; World Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Banjul.
  • Abdulkadir MB; Department of Paediatrics, Lagos University Teaching Hospital.
  • Bashir MF; Department of Paediatrics, College of Medicine, University of Lagos.
  • Okunola OP; Department of Paediatrics and Child Health, University of Ilorin Teaching Hospital.
  • Isiaka AH; Department of Paediatrics, Abubakar Tafawa Balewa University Teaching Hospital, Bauchi.
  • Lawal NM; Department of Child Health, University of Benin Teaching Hospital.
  • Edelu BO; WHO Country office, Abuja.
  • Onyejiaka N; Department of Disease Control and Immunization, National Primary Health Care Development Agency, Abuja.
  • Ihuoma CJ; Department of Paediatrics University of Nigeria Teaching Hospital Ituku-Ozalla, Enugu State.
  • Ndu F; Department of Medical Microbiology and Parasitology, Lagos University Teaching Hospital.
  • Ozumba UC; Department of Microbiology, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu State.
  • Udeinya F; Mother of Christ Specialist Hospital Enugu.
  • Ogunsola F; Department of Microbiology, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu State.
  • Saka AO; Department of Microbiology, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu State.
  • Fadeyi A; Department of Medical Microbiology and Parasitology, Lagos University Teaching Hospital.
  • Aderibigbe SA; Department of Paediatrics and Child Health, University of Ilorin Teaching Hospital.
  • Abdulraheem J; Department of Medical Microbiology and Parasitology, University of Ilorin Teaching Hospital, Kwara.
  • Yusuf AG; Department of Epidemiology and Community Health, University of Ilorin Teaching Hospital, Kwara.
  • Sylvanus Ndow P; Department of Medical Microbiology and Parasitology, University of Ilorin Teaching Hospital, Kwara.
  • Ogbogu P; Medical Microbiology Department, Abubakar Tafawa Balewa University Teaching Hospital, Bauchi.
  • Kanu C; World Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Banjul.
  • Emina V; Department of Medical Microbiology, University of Benin Teaching Hospital.
  • Makinwa OJ; Department of Community Health, University of Benin Teaching Hospital, and.
  • Gehre F; Department of Community Health and Primary Care, Lagos University Teaching Hospital, Nigeria.
  • Yusuf K; Department of Medical Microbiology and Parasitology, Lagos University Teaching Hospital.
  • Braka F; Department of Paediatrics University of Nigeria Teaching Hospital Ituku-Ozalla, Enugu State.
  • Mwenda JM; Department of Infectious Disease Epidemiology, Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, Germany.
  • Ticha JM; Department of Disease Control and Immunization, National Primary Health Care Development Agency, Abuja.
  • Nwodo D; WHO, Nigeria EPI Cluster Lead.
  • Worwui A; WHO Regional Office for Africa WHO/AFRO, Republic of Congo, Brazzaville.
  • Biey JN; WHO Country office, Abuja.
  • Kwambana-Adams BA; WHO Country office, Abuja.
  • Antonio M; World Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Banjul.
Clin Infect Dis ; 69(Suppl 2): S81-S88, 2019 09 05.
Article en En | MEDLINE | ID: mdl-31505626
ABSTRACT

BACKGROUND:

Historically, Nigeria has experienced large bacterial meningitis outbreaks with high mortality in children. Streptococcus pneumoniae (pneumococcus), Neisseria meningitidis (meningococcus), and Haemophilus influenzae are major causes of this invasive disease. In collaboration with the World Health Organization, we conducted longitudinal surveillance in sentinel hospitals within Nigeria to establish the burden of pediatric bacterial meningitis (PBM).

METHODS:

From 2010 to 2016, cerebrospinal fluid was collected from children <5 years of age, admitted to 5 sentinel hospitals in 5 Nigerian states. Microbiological and latex agglutination techniques were performed to detect the presence of pneumococcus, meningococcus, and H. influenzae. Species-specific polymerase chain reaction and serotyping/grouping were conducted to determine specific causative agents of PBM.

RESULTS:

A total of 5134 children with suspected meningitis were enrolled at the participating hospitals; of these 153 (2.9%) were confirmed PBM cases. The mortality rate for those infected was 15.0% (23/153). The dominant pathogen was pneumococcus (46.4% 71/153) followed by meningococcus (34.6% 53/153) and H. influenzae (19.0% 29/153). Nearly half the pneumococcal meningitis cases successfully serotyped (46.4% 13/28) were caused by serotypes that are included in the 10-valent pneumococcal conjugate vaccine. The most prevalent meningococcal and H. influenzae strains were serogroup W and serotype b, respectively.

CONCLUSIONS:

Vaccine-type bacterial meningitis continues to be common among children <5 years in Nigeria. Challenges with vaccine introduction and coverage may explain some of these finding. Continued surveillance is needed to determine the distribution of serotypes/groups of meningeal pathogens across Nigeria and help inform and sustain vaccination policies in the country.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Meningitis Bacterianas / Vigilancia de Guardia / Vacunas Neumococicas / Hospitalización Tipo de estudio: Observational_studies / Risk_factors_studies / Screening_studies Límite: Child, preschool / Female / Humans / Infant / Male / Newborn País/Región como asunto: Africa Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2019 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Meningitis Bacterianas / Vigilancia de Guardia / Vacunas Neumococicas / Hospitalización Tipo de estudio: Observational_studies / Risk_factors_studies / Screening_studies Límite: Child, preschool / Female / Humans / Infant / Male / Newborn País/Región como asunto: Africa Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2019 Tipo del documento: Article